» Articles » PMID: 30451892

Decreased BDNF Release in Cortical Neurons of a Knock-in Mouse Model of Huntington's Disease

Overview
Journal Sci Rep
Specialty Science
Date 2018 Nov 20
PMID 30451892
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Huntington's disease (HD) is a dominantly inherited neurodegenerative disease caused by an increase in CAG repeats in the Huntingtin gene (HTT). The striatum is one of the most vulnerable brain regions in HD, and altered delivery of BDNF to the striatum is believed to underlie this high vulnerability. However, the delivery of BDNF to the striatum in HD remains poorly understood. Here, we used real-time imaging to visualize release of BDNF from cortical neurons cultured alone or co-cultured with striatal neurons. BDNF release was significantly decreased in the cortical neurons of zQ175 mice (a knock-in model of HD), and total internal reflection fluorescence microscopy revealed several release patterns of single BDNF-containing vesicles, with distinct kinetics and prevalence, in co-cultured cortical HD neurons. Notably, a smaller proportion of single BDNF-containing vesicles underwent full release in HD neurons than in wild-type neurons. This decreased release of BDNF in cortical neurons might lead to decreased BDNF levels in the striatum because the striatum receives BDNF mainly from the cortex. In addition, we observed a decrease in the total travel length and speed of BDNF-containing vesicles in HD neurons, indicating altered transport of these vesicles in HD. Our findings suggest a potential mechanism for the vulnerability of striatal neurons in HD and offer new insights into the pathogenic mechanisms underlying the degeneration of neurons in HD.

Citing Articles

Brain-derived neurotrophic factor plays with TRiC: focus on synaptic dysfunction in Huntington's disease.

Gu Y, Sung K, Wu C Neural Regen Res. 2024; 20(10):2919-2920.

PMID: 39610103 PMC: 11826460. DOI: 10.4103/NRR.NRR-D-24-00679.


Selective Noradrenergic Activation of BDNF Translation by Mirtazapine.

Ciraci V, Santoni L, Tongiorgi E Mol Neurobiol. 2024; .

PMID: 39557799 DOI: 10.1007/s12035-024-04619-1.


Heavy Metal Interactions with Neuroglia and Gut Microbiota: Implications for Huntington's Disease.

Tizabi Y, Bennani S, El Kouhen N, Getachew B, Aschner M Cells. 2024; 13(13.

PMID: 38994995 PMC: 11240758. DOI: 10.3390/cells13131144.


BDNF and TRiC-inspired reagent rescue cortical synaptic deficits in a mouse model of Huntington's disease.

Gu Y, Pope A, Smith C, Carmona C, Johnstone A, Shi L Neurobiol Dis. 2024; 195:106502.

PMID: 38608784 PMC: 11890210. DOI: 10.1016/j.nbd.2024.106502.


Altered exocytosis of inhibitory synaptic vesicles at single presynaptic terminals of cultured striatal neurons in a knock-in mouse model of Huntington's disease.

Xu C, Chen S, Chen X, Ho K, Park C, Yoo H Front Mol Neurosci. 2023; 16:1175522.

PMID: 37664244 PMC: 10470468. DOI: 10.3389/fnmol.2023.1175522.


References
1.
Huang E, Reichardt L . Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001; 24:677-736. PMC: 2758233. DOI: 10.1146/annurev.neuro.24.1.677. View

2.
Larson J, Munkacsy E . Theta-burst LTP. Brain Res. 2014; 1621:38-50. PMC: 4411212. DOI: 10.1016/j.brainres.2014.10.034. View

3.
Mackenzie K, Duffield M, Peiris H, Phillips L, Zanin M, Teo E . Huntingtin-associated protein 1 regulates exocytosis, vesicle docking, readily releasable pool size and fusion pore stability in mouse chromaffin cells. J Physiol. 2013; 592(7):1505-18. PMC: 3979608. DOI: 10.1113/jphysiol.2013.268342. View

4.
Baquet Z, Gorski J, Jones K . Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci. 2004; 24(17):4250-8. PMC: 6729276. DOI: 10.1523/JNEUROSCI.3920-03.2004. View

5.
Cattaneo E, Zuccato C, Tartari M . Normal huntingtin function: an alternative approach to Huntington's disease. Nat Rev Neurosci. 2005; 6(12):919-30. DOI: 10.1038/nrn1806. View